Place des thérapies ciblées chez la patiente âgée atteinte de cancer du sein
Author:
Publisher
Computers, Materials and Continua (Tech Science Press)
Subject
Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10269-011-1996-x.pdf
Reference33 articles.
1. Baselga J, Gelmon KA, Verma S, et al. (2010) Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy. J Clin Oncol 28(7): 1138–1144
2. Brufsky A, Bondarenko I, Smirnov V, et al (2009) RIBBON-2: a randomized, double blind, placebo-controlled, phase III trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy for second-line treatment of HER2-negative metastatic breast cancer. Cancer Res 69(24 Suppl): Abstract nr 42
3. Burstein HJ, Sun Y, Dirix LY, et al. (2010) Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer. J Clin Oncol 28(8): 1301–1307
4. Chaibi P, Magne N, Breton S, et al (2010) Influence of geriatric consultation with comprehensive geriatric assessment on final therapeutic decision in elderly cancer patients. Crit Rev Oncol Hematol [Epub ahead of print]
5. Cutuli B, De Lafontan B, Vitali E, et al. (2009) Breast conserving treatment (BCT) for stage I-II breast cancer in elderly women: analysis of 927 cases. Crit Rev Oncol Hematol 71(1): 79–88
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3